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 How should we use the 
coronary artery calcium score 
to predict cardiovascular risk?
 the coronary artery calcium
 (CAC) score—an indepen-
dent predictor of cardiovascular events 
(strength of recommendation [SOR]: C, 
systematic review of disease-oriented out-
comes)—can be used, in addition to tra-
ditional risk factor assessment, to further 
stratify the risk of coronary heart disease 
(CHD) in asymptomatic patients (SOR: C, 
multiple large observational studies with 
disease-oriented outcomes). 
Although a high CAC score is associ-
ated with a greater risk of cardiovascular 
disease, no studies have evaluated cardio-
vascular outcomes of CAC-guided treat-
ment, so its value remains theoretical.
Evidence summary
Most atherosclerotic lesions are calcifi ed. Th e 
degree of calcifi cation is proportional to the 
severity of atherosclerosis and can be quan-
tifi ed by the CAC score as measured by elec-
tron beam computed tomography (EBCT).1 
As the CAC score rises, so does risk
A systematic review of 9 studies evaluated the 
relationship between CAC scores and coro-
nary artery disease (CAD) in asymptomatic 
patients (TABLE). CAD was measured by such 
clinical outcomes as unstable angina, myo-
cardial infarction, stroke, coronary death, 
all-cause mortality, or need for revasculariza-
tion. Th e relative risk of CAD for a moderate 
CAC score compared with a low score was 3.5 
(95% confi dence interval [CI], 2.4-5.1) and for 
a high score compared with a low score was 
9.9 (95% CI, 5.3-17.6). Some of the studies 
were of poor quality, including self-referred 
patients, for example.2
A subsequent study found similar asso-
ciations. Th e observational study of 25,253 
asymptomatic individuals referred for CAC 
testing to assess cardiovascular risk demon-
strated that CAC was an independent pre-
dictor of all-cause mortality. After a mean of 
6.8 years, the adjusted relative risk increased 
incrementally from 1.48 (95% CI, 0.71-3.07) 
for a CAC score of 1 to 10, to 9.36 (95% CI, 
5.36-16.33) for a score ≥1,000, compared with 
a score of 0.3
CAC predicts risk, but does it improve
treatment or outcomes?
Analysis of 3201 women followed for an aver-
age of 3.75 years in the Multi-Ethnic Study of 
Atherosclerosis cohort revealed that women 
at low Framingham risk, but with detectable 
CAC, had an increased risk of CHD (hazard 
ratio [HR]=6.5; 95% CI, 2.6-16.4) and car-
diovascular disease events (HR=5.2; 95% CI, 
2.5-10.8).4 
Th e St. Francis Heart Study prospectively 
compared CAC with standard CHD risk fac-
tors for predicting atherosclerotic cardio-
vascular disease (ASCVD) events in 4903 
asymptomatic people between 50 and 70 
years of age. For CAC scores ≥100 compared 
with scores <100, relative risk was 9.6 (95% CI, 
6.7-13.9) for all ASCVD events, 11.1 (95% CI, 
7.3-16.7) for all CHD events, and 9.2 (95% CI, 
4.9-17.3) for nonfatal myocardial infarction 
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and death. Th e CAC score predicted CHD 
events more accurately than standard risk 
factors and reclassifi ed 24% of intermediate-
risk women and 17% of intermediate-risk men 
into a higher-risk group.5
Despite studies that correlate higher CAC 
score with increased cardiovascular risk, we 
found no evidence that testing leads to im-
proved treatment for preventing CHD or bet-
ter cardiovascular outcomes.
Recommendations 
Th e American College of Cardiology sug-
gests that measuring CAC may be reasonable 
for asymptomatic patients with intermedi-
ate CHD risk (10%-20% 10-year risk of CHD 
events), for whom elevated CAC scores could 
lead to a higher-risk classifi cation and subse-
quent modifi cation of management.6 Th e Col-
lege doesn’t recommend evaluating CAC in 
patients with low CHD risk, because it would 
constitute screening the general population, 
or asymptomatic patients with high CHD risk, 
who are already candidates for intensive risk 
modifi cation. 
Th e US Preventive Services Task Force 
conducted its own review and concluded that 
although the CAC score is an independent 
predictor of major CHD events, insuffi  cient 
evidence exists to support its use to further 
stratify risk in intermediate-risk patients.7     JFP
TABLE
What does that CAC 
score mean?1
Score Severity of disease
<1 No identifi able disease
1-10 Mild 
11-100 Moderate 
101-400 Moderate to high 
>400 Severe 
CAC, coronary artery calcium.
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